Zscaler Shares Slide 24 Premarket Following Cautious FullYear Guidance Market Update Zimmer Biomet AnheuserBusch InBev and Viatris See Mixed Trading Activity Trump Seeks Supreme Court Intervention to Halt TikTok Ban Microsofts GitHub Faces New AI Coding Competition Amid Service Disruptions OpenAIs Potential IPO Could Be Largest in History Challenging SpaceXs Lead EasyJet Assures Summer Flight Schedule Unaffected by Jet Fuel Supply Concerns ACGL Q1 2026 Earnings Slight EPS Miss Highlights Strong Underwriting Amid Market Headwinds Reliance Inc RS Q1 2026 Earnings Strong EPS Beat Drives Stock Higher PD Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency CNH Q1 2026 Earnings EPS Beats Estimates by 75 Stock Declines Slightly CNXN Q1 2026 Earnings EPS Surges Past Estimates with 2478 Surprise Centuri Holdings Inc CTRI Q1 2026 Earnings Narrowing Loss Beats Expectations on Cost Discipline Eaton Vance EXG Posts Modest Gain Approaches Key Resistance Zone Aclaris Therapeutics Holds Steady Near MidRange as Traders Eye Key Support and Resistance Lennox International LII Holds Steady Near 503 Consolidating Within Recent Range NatWest NWG Holds Near Support After Modest Decline Key Levels to Watch Relmada Therapeutics Inc RLMD Slips 236 as Stock Tests Key Support Levels MSGS Q1 2026 Earnings EPS Falls Well Below Estimates as Stock Holds Steady CIM Q1 2026 Earnings Modest EPS Beat as Interest Rate Dynamics Shape Performance ZD Q1 2026 Earnings EPS Misses Estimates Stock Rises on Strategic Progress ADIL Q1 2026 Earnings Narrowed Loss Beats Estimates but Market Remains Cautious MTEX Q3 2023 Earnings Narrow Profit as Stock Gains FTSE 100 Breaks FourWeek Losing Streak as Softer Inflation and Rising Jobless Data Ease BoE Rate Hike Concerns Trane Technologies Q1 2026 Earnings EPS Beats Estimates Amid Strong Operational Performance Embecta Corp EMBC Holds Steady at 332 as Traders Await Clear Direction Bank of New York Mellon BK Holds Steady at 13716 as Buyers and Sellers Remain Balanced Allogene Therapeutics Edges Higher Testing Key Resistance at 21 Ocular Therapeutix OCUL Holds Steady Near 827 as Shares Edge Higher Intellia Therapeutics NTLA Rebounds GeneEditing Stock Shows Promise Near Support First Community Bankshares FCBC Holds Steady Near 42 Level Amid Sector Caution Fusemachines FUSE Holds Steady Near 142 as Key Levels Come into Focus Eaton Vance Dividend Fund EVT Edges Higher as Income Demand Persists